Jane Street’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Jane Street’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-28,498	Closed	-$190K	–	10000
2023 Q3	$190K	Buy	28,498 +13,916	+95%	+$116K	﹤0.01%	7659
2023 Q2	$132K	Sell	14,582 -79,654	-85%	-$703K	﹤0.01%	7877
2023 Q1	$685K	Buy	94,236 +65,492	+228%	+$486K	﹤0.01%	5756
2022 Q4	$210K	Buy	+28,744	New	+$213K	﹤0.01%	7606
2022 Q2	–	Sell	-47,366	Closed	-$378K	–	11264
2022 Q1	$378K	Buy	+47,366	New	+$301K	﹤0.01%	7991

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Jane Street's PNT Position: Q4 2023 in Review

Jane Street sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 28,498 shares — an estimated $190K sold.

Jane Street first reported a position in PNT in Q1 2022 and held it in 5 quarters. The position peaked at $685K in Q1 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

Jane Street reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
Jane Street sold 28,498 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $190K.
Jane Street first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2022 and held it in 5 quarters.
Jane Street's POINT Biopharma Global Inc. Common Stock position peaked at $685K in Q1 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Jane Street's 13F filing for Q4 2023, filed 15 Feb 2024.